Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)

Clinical trial NCT00722735 · COMPLETED

Trial details

NCT number: NCT00722735
Sponsor: MerLion Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Tract Infections

Start date: 2008-10-01
Primary completion: 2009-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.